These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33182594)

  • 1. Deciphering Fatty Acid Synthase Inhibition-Triggered Metabolic Flexibility in Prostate Cancer Cells through Untargeted Metabolomics.
    Oh JE; Jung BH; Park J; Kang S; Lee H
    Cells; 2020 Nov; 9(11):. PubMed ID: 33182594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer drugs targeting fatty acid synthase (FAS).
    Pandey PR; Liu W; Xing F; Fukuda K; Watabe K
    Recent Pat Anticancer Drug Discov; 2012 May; 7(2):185-97. PubMed ID: 22338595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells.
    Qiao S; Pennanen P; Nazarova N; Lou YR; Tuohimaa P
    J Steroid Biochem Mol Biol; 2003 May; 85(1):1-8. PubMed ID: 12798352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D3 inhibits fatty acid synthase expression by stimulating the expression of long-chain fatty-acid-CoA ligase 3 in prostate cancer cells.
    Qiao S; Tuohimaa P
    FEBS Lett; 2004 Nov; 577(3):451-4. PubMed ID: 15556626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens and the control of lipid metabolism in human prostate cancer cells.
    Swinnen JV; Verhoeven G
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):191-8. PubMed ID: 9699873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.
    Brusselmans K; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Int J Cancer; 2003 Oct; 106(6):856-62. PubMed ID: 12918062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipidomics Profiling Reveals Differential Alterations after FAS Inhibition in 3D Colon Cancer Cell Culture Models.
    Fries BD; Tobias F; Wang Y; Holbrook JH; Hummon AB
    J Proteome Res; 2024 Aug; 23(8):2919-2933. PubMed ID: 38063332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NADPH accumulation is responsible for apoptosis in breast cancer cells induced by fatty acid synthase inhibition.
    Cui Y; Xing P; Wang Y; Liu M; Qiu L; Ying G; Li B
    Oncotarget; 2017 May; 8(20):32576-32585. PubMed ID: 28427229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic alterations and targeted therapies in prostate cancer.
    Flavin R; Zadra G; Loda M
    J Pathol; 2011 Jan; 223(2):283-94. PubMed ID: 21125681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells.
    Van de Sande T; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Cancer Res; 2002 Feb; 62(3):642-6. PubMed ID: 11830512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
    Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer.
    Swinnen JV; Roskams T; Joniau S; Van Poppel H; Oyen R; Baert L; Heyns W; Verhoeven G
    Int J Cancer; 2002 Mar; 98(1):19-22. PubMed ID: 11857379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell metabolomics identify regulatory pathways and targets of magnoline against prostate cancer.
    Sun H; Zhang AH; Liu SB; Qiu S; Li XN; Zhang TL; Liu L; Wang XJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():143-151. PubMed ID: 30391728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer.
    Balaban S; Nassar ZD; Zhang AY; Hosseini-Beheshti E; Centenera MM; Schreuder M; Lin HM; Aishah A; Varney B; Liu-Fu F; Lee LS; Nagarajan SR; Shearer RF; Hardie RA; Raftopulos NL; Kakani MS; Saunders DN; Holst J; Horvath LG; Butler LM; Hoy AJ
    Mol Cancer Res; 2019 Apr; 17(4):949-962. PubMed ID: 30647103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid synthase: a metabolic oncogene in prostate cancer?
    Baron A; Migita T; Tang D; Loda M
    J Cell Biochem; 2004 Jan; 91(1):47-53. PubMed ID: 14689581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells.
    Little JL; Wheeler FB; Fels DR; Koumenis C; Kridel SJ
    Cancer Res; 2007 Feb; 67(3):1262-9. PubMed ID: 17283163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity.
    Brusselmans K; Vrolix R; Verhoeven G; Swinnen JV
    J Biol Chem; 2005 Feb; 280(7):5636-45. PubMed ID: 15533929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conditional mutant of the fatty acid synthase unveils unexpected cross talks in mycobacterial lipid metabolism.
    Cabruja M; Mondino S; Tsai YT; Lara J; Gramajo H; Gago G
    Open Biol; 2017 Feb; 7(2):. PubMed ID: 28228470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
    Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
    Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.